The Benchmark

CVS split is a shelf reset. Move before the dust settles.

Two companies where one stood means two procurement teams, two planogram cycles, and one open lane for brands that act in Q1.

MarketplaceBy The Beacon desk, Lighthouse Strategy

Data pulse

2

Distinct companies CVS Health plans to create

Source: Digital Commerce 360

CVS Health is splitting in two. The retail pharmacy chain separates from the health care insurance and services units, each becoming a distinct company. That is not a headline you read and move on from. That is a structural event that resets every vendor relationship inside one of the largest retail health destinations in the country. Your category manager does not exist in the same org anymore. Your planogram approval chain just changed. Your co-op budget sits inside a business that is now being carved out of the one that sets the shelf.

What actually breaks when a buyer splits

Separations move slower than announcements. The press release drops today. The procurement teams do not fully bifurcate for another 12 to 24 months. That gap is the window. Category teams inside transitioning retailers default to incumbent SKUs during uncertainty. They do not have bandwidth to audit new entrants. They do have bandwidth to cut underperformers. If your velocity rank inside CVS pharmacy locations is soft, you are on the wrong side of that default. Tight sell-through data and clean NetPPM presentation is what keeps you on the planogram while the org chart reshuffles.

Two buyers means two separate pitches

Post-split, the retail pharmacy entity and the health care services entity will have separate leadership, separate P&Ls, and separate category priorities. Health and beauty brands that cross both channels need to map that now. A lip treatment sold through the front-of-store pharmacy retail shelf is a retail pharmacy problem. A wellness supplement bundled through care services is a different conversation entirely. Brands that treat these as one buyer after the split will get routed to whoever picks up the phone first. That is not a strategy. That is luck.

Build two pitch decks. Separate landing cost models for each entity. Understand which of your ASINs or retail SKUs index higher with the pharmacy consumer versus the managed care or benefits-adjacent consumer. Those are different cohorts with different purchase triggers. Retail pharmacies optimize for basket conversion on the floor. Health services entities optimize for formulary economics and member outcomes. Know which bucket your SKU lives in before you walk into either room.

The incoming category negotiation cycle

Retail pharmacies face structural pressure. The Digital Commerce 360 report notes that the split comes as retail pharmacies broadly are under stress. That stress produces one reliable behavior: category consolidation. Buyers under margin pressure cut the long tail first. Mid-tier SKUs with average velocity and no promotional commitment get delisted before anything else. If you are in CVS with one or two SKUs and no incremental trade investment on the books, your position is fragile. The transition period accelerates the timeline on that fragility.

The counter-move is to get a Q1 2027 commitment on paper before the new entity structures its buying team. Existing vendor agreements may carry through separation or may require renegotiation depending on how CVS structures the legal split. Do not assume continuity. Ask your broker or direct buyer contact explicitly which agreements transfer to which entity. Get it in writing. That is not paranoia. That is basic landed cost protection.

Three questions to pressure-test

First: Which of your CVS SKUs generate enough velocity to survive a category audit by a new buyer who does not know your brand story? Velocity data only. No relationship credit. Second: If your current buyer contact moves to the health services entity instead of retail pharmacy, do you have a named contact on the retail side who can champion your planogram position in the next line review? Third: Has your trade investment been structured as a single-entity agreement that may not automatically extend to whichever new company holds the retail pharmacy shelf?

From the publisher

Reading is free. Acting on it is where we come in.

When a story is about your category, a Discovery call turns it into a plan.